• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Supporting Musculoskeletal Health: Tending to Muscles, Joints, and Bones

    2023 Contract Manufacturing Survey

    Dosage and Delivery Innovations Help Manufacturers Meet Common Challenges

    A Paradigm Shift for Antioxidants?

    Manufacturing Dietary Supplements in Economic Uncertainty
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Glossary
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    'What’s Up With Supps' Event at Expo West Raises Over $8,000 for Vitamin Angels

    IRI and NPD Rebrand as Circana Following Merger

    ABC’s Sustainable Herbs Program Updates Sustainability and Regenerative Practices Toolkit

    HP Ingredients Introduces NuFemme, Herbal Blend for Women’s Hormonal Support

    World Economic Forum Names Sofia Elizondo of Brightseed a Young Global Leader
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    ABC’s Sustainable Herbs Program Updates Sustainability and Regenerative Practices Toolkit

    HP Ingredients Introduces NuFemme, Herbal Blend for Women’s Hormonal Support

    World Economic Forum Names Sofia Elizondo of Brightseed a Young Global Leader

    Disappearing Act: The Battle Over Dietary Supplement Ingredients and the Drug Exclusion Provision

    Cucumber Extract May Improve Joint Function
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    'What’s Up With Supps' Event at Expo West Raises Over $8,000 for Vitamin Angels

    IRI and NPD Rebrand as Circana Following Merger

    ABC’s Sustainable Herbs Program Updates Sustainability and Regenerative Practices Toolkit

    World Economic Forum Names Sofia Elizondo of Brightseed a Young Global Leader

    Intake of Live Microbes from the Diet, Including Fermented Foods, Associated with Better Health
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    'What’s Up With Supps' Event at Expo West Raises Over $8,000 for Vitamin Angels

    HP Ingredients Introduces NuFemme, Herbal Blend for Women’s Hormonal Support

    World Economic Forum Names Sofia Elizondo of Brightseed a Young Global Leader

    Intake of Live Microbes from the Diet, Including Fermented Foods, Associated with Better Health

    Cucumber Extract May Improve Joint Function
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Botanic Healthcare LLC

    Verdure Sciences

    Xsto Solutions

    EIRICH Machines

    PhytoGaia Inc
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Botanic Healthcare LLC

    Verdure Sciences

    Xsto Solutions

    EIRICH Machines

    PhytoGaia Inc
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Rough Road Ahead for Medical Foods?

    Recent FDA activity suggests increased scrutiny of the category and more aggressive enforcement.

    Rough Road Ahead for Medical Foods?
    Rough Road Ahead for Medical Foods?
    Gregory Stephens, RD, Windrose Partners11.01.13
    In the last Business Insights column I discussed a renewed convergence of the dietary supplement and pharmaceutical industries. This was a hot hallway topic at several recent conferences. The fact that pharmaceutical and consumer packaged goods (CPG) companies are once again investing in dietary supplement brands is something of a concern to supplement companies. The example often cited is Procter & Gamble’s acquisition of New Chapter. On the other hand, pharmaceutical companies have noted that the medical food business is being encroached upon by supplement companies, which appear anxious to enter this rapidly growing market. Such conversations are not new; the names and regulatory categories change but competiveness is a mainstay of our industry.

    There are several factors driving medical foods into the spotlight. Globally, it is a rapidly growing multibillion-dollar market. Secondly, through guidance documents and enforcement actions, FDA is beginning to raise concern about the viability of the market.

    FDA Enforcement Actions
    There has been much discussion over the past year about FDA tightening down on structure-function claims. A good example is the recent FDA enforcement activity around inflammation related claims. Sometimes out of frustration, dietary supplement company executives have suggested that going the medical food route may open new doors not accessible to dietary supplements. Not only can medical foods make “disease management” label claims, the classification may also elevate the perception of efficacy for their products.

    Most people in the industry are now aware of the basic definition of a medical food: Foods that help to manage a disease or condition by meeting the “distinctive nutritional requirements” that the disease or condition creates. For example, FDA pointed out that some inborn errors of metabolism like phenylketonuria (PKU) require considerable modification of the diet to avoid phenylalanine in order to avoid serious medical issues. It is difficult for PKU patients to achieve these dietary modifications, thus the need for medical foods to help manage the condition.

    For years the pharmaceutical medical food companies (e.g., Nestle and Abbott Nutrition) have walked a fine line with FDA on medical food requirements, yet not without occasional confrontation. However, over the past few years, supplement companies and start-ups have taken this opportunity to expand the indications for medical foods to a much broader range of diseases. I have commented before that many of these companies seem to be “flying under the FDA radar.”  That is, they do not present a significant enough threat to consumers to warrant the FDA’s attention, given their limited resources. Based on the agency’s actions over the past few months, it appears FDA is beginning to pay increasing attention to the category. FDA’s new draft Medical Foods Guidance Document and Q&As, as well as a number of recent warning letters disallowing medical food products, indicate the agency is determined to interpret the definition of medical food narrowly and prohibit the marketing of many novel products that might fit into this category.

    Recently, a major supplement company in the practitioner channel received a warning letter from FDA addressing several of its products marketed as medical foods. In the letter, FDA stated, “these products are labeled as ‘medical foods,’ and the labeling claims on your website represent these products as medical foods for the dietary management of a variety of medical conditions.”

    Based on the FDA review of the company’s website, it was determined that 14 of its medical food labeled products were misbranded, not meeting the statutory definition. Thus, FDA stated the claims made on these products cause them to be unapproved drugs.

    Key to FDA’s action are elements of the statutory definition of medical foods. Specifically, a medical food is “a food which is formulated to be consumed or administered enterally under the supervision of a physician and which is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation.” Also, a medical food must be intended for a patient who has a limited or impaired capacity to ingest, digest, absorb or metabolize ordinary foodstuffs or certain nutrients, or who has other special medically determined nutrient requirements, the dietary management of which cannot be achieved by modification of the normal diet alone.

    The warning letter references the company’s products that target numerous health conditions: chronic fatigue syndrome, fibromyalgia, leaky gut syndrome, metabolic syndrome and cardiovascular disease, inflammatory bowel conditions and/or inflammatory bowel disease, type 2 diabetes, atopic disorders such as eczema, rhinitis and allergy-responsive asthma, pre- and post-operative bariatric patients and peripheral artery disease.

    For these conditions, FDA stated it is not aware of any (not all apply to each indication):

    • Evidence that patients with these conditions have a limited or impaired capacity to ingest, digest, absorb or metabolize any specific nutrients;
    • Distinctive nutritional requirement for patients with these conditions…that cannot be met through dietary modification alone.

    Interestingly, for the bariatric product, FDA noted that a patient’s nutritional requirements can be met through dietary modification alone, “which may include use of a daily multi-vitamin.” Here we have the FDA suggesting use of a dietary supplement as a modification to the normal diet.

    Additionally, FDA noted the products are not Generally Recognized As Safe (GRAS) and effective for their referenced uses and, therefore, the products are “new drugs,” which cannot be legally introduced without prior approval from FDA. One of the unique differences between medical foods and dietary supplements is that ingredients in a medical food must be GRAS.

    FDA Draft Guidance and Q&A on Medical Foods
    The recently issued Medical Food Guidance/Q&A document will likely impact the development of these products. The majority of this guidance document appears quite similar to the 1996 “Regulation of Medical Foods: Advance Notice of Proposed Rulemaking (ANPR),” which was subsequently withdrawn by FDA in 2003 due to a “lack of activity, lack of resources, change in priorities”—though the agency stated the opinions expressed are still the same. The new guidance document reflects a renewed focus on this class of foods.

    In the most recent guidance document, FDA seems to take direct aim at what is currently the largest indication for medical foods: diabetes. The agency acknowledged there are distinctive nutritional requirements for patients with diabetes, but also stated it does not see type 1 or type 2 diabetes as conditions that require a medical food. FDA pointed out that a regular diet can be modified to meet the needs of patients with either type of diabetes. Certainly, FDA does not consider today’s consumers’ lifestyles, where adhering to a diabetic regimen may be much more realistic with convenient, healthy snacks and meal replacements.

    This invites the question: what about legacy products like Boost Glucose Control (Nestle) and Glucerna (Abbott Nutrition)? Both are labeled and marketed at retail with medical food claims. These brands are not small; collectively, estimated retail and institutional sales (e.g., hospitals and nursing homes) exceed $300 million annually in the U.S. alone.

    FDA points out that medical foods are necessary for select conditions. PKU being one where modification of the diet can possibly be achieved; however, that would be rather difficult. Where is the line to be drawn? How difficult must modification of the diet be for FDA to consider it appropriate to be a medical food?

    What’s Next?
    The Medical Food Guidance Document and recent warning letters suggest the category is being looked over closely, and it’s fair to expect more aggressive enforcement action. Still, for decades, very large pharmaceutical companies have invested heavily in research and development and promotion of medical foods.

    Thus, contrary to comments I’ve heard, the medical food category is not going away. It serves a valuable need for patients with some very serious health conditions. There are very reputable companies committed to developing new, innovative products in this billion-dollar industry. The challenge will be to continue funding research, including cost-benefit studies, and communicating with health practitioners, government agencies and Congress to protect the interests of patients who benefit from this much needed class of disease-management products.  


    Save the Date: The Second Annual Health Practitioner Market Forum, April 2-4, 2014, Hotel Maya – Long Beach, CA. Position your company for success in the health practitioner channel and the market for medical foods. Contact: Greg Stephens, 215-860-5186; E-mail: gregstephens@windrosepartners.com; Website: www.HPMForum.com.


    Greg Stephens, RD, is president of Windrose Partners, a company serving clients in the the dietary supplement, functional food and natural product industries. Formerly vice president of strategic consulting with The Natural Marketing Institute (NMI) and Vice President of Sales and Marketing for Nurture, Inc (OatVantage), he has 25 years of specialized expertise in the nutritional and pharmaceutical industries. His prior experience includes a progressive series of senior management positions with Abbott Nutrition (Ross Products Division of Abbott Laboratories), including development of global nutrition strategies for disease-specific growth platforms and business development for Abbott’s medical foods portfolio. He can be reached at 215-860-5186; E-mail: gregstephens@windrosepartners.com.
    Related Searches
    • GRAS
    • Nutrient
    • Dietary Supplements
    • Nutrition
    Related Knowledge Center
    • Inflammation
    • Medical Nutrition
    • Regulations
    • Functional Foods & Beverages
    • Healthcare Trends
    • Dietary Supplements
    Suggested For You
    Entrinsic Bioscience Expands Medical Food Line with enterade IBS-D Entrinsic Bioscience Expands Medical Food Line with enterade IBS-D
    Nutraceuticals Nutraceuticals
    Registered Dietitians in the Natural Products Industry: Friend or Foe? Registered Dietitians in the Natural Products Industry: Friend or Foe?
    ChromaDex Partners with MyPharma2Go for Brazilian Distribution ChromaDex Partners with MyPharma2Go for Brazilian Distribution
    Medical Food Addresses Fatty Acid Deficiencies, May Help Manage ADHD Symptoms Medical Food Addresses Fatty Acid Deficiencies, May Help Manage ADHD Symptoms
    Guardion Inks Testing Agreement with OmegaQuant Guardion Inks Testing Agreement with OmegaQuant
    ‘You Are What You Eat’ (Chapter 2): Nutrigenetics & Nutrigenomics ‘You Are What You Eat’ (Chapter 2): Nutrigenetics & Nutrigenomics
    Autophagy (the Body’s Garbage Disposal) Key to Cellular Renewal Autophagy (the Body’s Garbage Disposal) Key to Cellular Renewal
    The Nuts and Bolts of FDA’s 2023 Budget Request The Nuts and Bolts of FDA’s 2023 Budget Request
    Lanfam LLC Launches Medical Food for Pain Relief Lanfam LLC Launches Medical Food for Pain Relief
    The Value of Clinical Evidence Supporting Nutraceuticals The Value of Clinical Evidence Supporting Nutraceuticals
    NEM Eggshell Membrane Receives Novel Food Approval from India’s FSSAI NEM Eggshell Membrane Receives Novel Food Approval from India’s FSSAI
    Astaxanthin: The Rising Star for Developing New Immune Products Astaxanthin: The Rising Star for Developing New Immune Products
    Understanding Exclusion (Preclusion) and a Proposed Solution Understanding Exclusion (Preclusion) and a Proposed Solution
    Claims Spell Success in Today’s Nutritional Products Market Claims Spell Success in Today’s Nutritional Products Market

    Related Breaking News

    • Breaking News | Digestive Health | Medical Nutrition | Products | Proteins, Peptides, Amino Acids
      Entrinsic Bioscience Expands Medical Food Line with enterade IBS-D

      Entrinsic Bioscience Expands Medical Food Line with enterade IBS-D

      Formula of amino acids and electrolytes supports digestive function while replenishing fluid loss and minerals.
      02.21.23

    • Nutraceuticals

      ...
      11.14.22

    • Dietary Supplements | Healthcare Trends | Medical Nutrition
      Registered Dietitians in the Natural Products Industry: Friend or Foe?

      Registered Dietitians in the Natural Products Industry: Friend or Foe?

      The natural products industry is evolving in many ways, with rapid growth and increased sales. Dietitians are playing a sizable role.
      By Greg Stephens, Windrose Partners and Sheila Campbell, PhD, RD 09.08.22


    • Breaking News | Dietary Supplements | Healthy Aging | Industry & Market News | World Markets
      ChromaDex Partners with MyPharma2Go for Brazilian Distribution

      ChromaDex Partners with MyPharma2Go for Brazilian Distribution

      Brazil will now be the first Latin American country to have Tru Niagen available on its market.
      09.02.22

    • Breaking News | Fatty Acids | Infant & Children's Health | Medical Nutrition | Products
      Medical Food Addresses Fatty Acid Deficiencies, May Help Manage ADHD Symptoms

      Medical Food Addresses Fatty Acid Deficiencies, May Help Manage ADHD Symptoms

      Equazen Pro is now available in the U.S. through SFI Health.
      07.18.22

    Loading, Please Wait..
    Trending
    • Shiitake Mushroom Extract Appears Helpful In HPV Infections
    • The Functional Chocolate Company Launches Painfree Chocolate
    • HMB And Vitamin D Supplementation Linked To Reduction In Fat Stores
    • Amazon Bans Dietary Supplements Containing NMN
    Breaking News
    • 'What’s Up With Supps' Event at Expo West Raises Over $8,000 for Vitamin Angels
    • IRI and NPD Rebrand as Circana Following Merger
    • ABC’s Sustainable Herbs Program Updates Sustainability and Regenerative Practices Toolkit
    • HP Ingredients Introduces NuFemme, Herbal Blend for Women’s Hormonal Support
    • World Economic Forum Names Sofia Elizondo of Brightseed a Young Global Leader
    View Breaking News >
    CURRENT ISSUE

    March 2023

    • Supporting Musculoskeletal Health: Tending to Muscles, Joints, and Bones
    • Dosage and Delivery Innovations Help Manufacturers Meet Common Challenges
    • 2023 Contract Manufacturing Survey
    • Manufacturing Dietary Supplements in Economic Uncertainty
    • Beyond Antioxidants: The Power of Berries
    • A Paradigm Shift for Antioxidants?
    • Ayana Bio on Path to Scale Bioactives Derived from Plant Cell Cultures
    • Nuritas: Leveraging Artificial Intelligence to Speak the Language of Life
    • Dietary Supplement Quality Assurance Programs Critical to Natural Products Industry Success
    • Innovation in Nutraceuticals: Dose Forms and Application Science Help Meet Consumer Demand
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    'What’s Up With Supps' Event at Expo West Raises Over $8,000 for Vitamin Angels
    IRI and NPD Rebrand as Circana Following Merger
    ABC’s Sustainable Herbs Program Updates Sustainability and Regenerative Practices Toolkit
    Coatings World

    Latest Breaking News From Coatings World

    Miller Paint Partners with Portland Boutique Woonwinkel for 2023 Spring Color Trends
    ALTANA Reports Sales of €3 Billion for First Time in 2022
    Dunn-Edwards Launches New Dead Flat Ceiling Paint
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—March 18
    Schurter Launches 5121 Filtered Appliance Inlet
    Suzanne Foster Joins Perimeter Medical Imaging AI Board
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Enzo Biochem Sells Clinical Laboratory to Labcorp
    53Biologics Expands its State-of-the-art Facilities
    Grand River Aseptic Manufacturing Receives Zero Observations from FDA Inspection
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Soapbox Launches New Moisturizing Hand Soaps at Walmart Stores
    Revlon Plans to Emerge from Chapter 11 Bankruptcy in April 2023
    Dial Unveils New and Improved Body Washes
    Happi

    Latest Breaking News From Happi

    Byoma Enters Suncare with New Moisturizing Gel-Cream SPF 30
    Red Carpet Looks at the Academy Awards and Apollo Buys Univar
    Laneige Launches Hydration Deep Dive Campaign Featuring Actress Sydney Sweeney
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: Energy Curable Inks, Toyo Ink, Resins Top This Week’s Stories
    ALTANA Achieves Sales of €3 Billion for First Time in 2022
    Ball Corporation Releases Climate Transition Plan
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    UPM Raflatac analyzes supply chain, TLMI hosts Converter Meeting and more
    Education sessions announced for Dscoop Edge St. Louis World Expo
    ALTANA reports record sales in 2022
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Weekly Recap: TerraCycle Launches Diaper Program, Ahlstrom to Divest or Shutter Stenay Plant & More
    Mativ Names CFO
    Indorama Ventures, Polymateria Partner on Biotransformation Technology
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—March 18
    Accelus' Remi Robotic Navigation OK'ed for GE OEC 9900 C-Arm
    AAOS News: Annunziato (Ned) Amendola Named Second Vice-President
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: LOPEC 2023 Slideshow, Dracula Technologies Top This Week’s Stories
    ALTANA Achieves Sales of €3B for First Time in 2022
    MClimate Releases Maintenance-Free Wireless Thermostat

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login